These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11457860)

  • 1. Insulin-like growth factor receptor levels are regulated by cell density and by long term estrogen deprivation in MCF7 human breast cancer cells.
    Stephen RL; Shaw LE; Larsen C; Corcoran D; Darbre PD
    J Biol Chem; 2001 Oct; 276(43):40080-6. PubMed ID: 11457860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of insulin-like growth factor II (IGFII) in ZR-75-1 human breast cancer cells: higher threshold levels of receptor (IGFIR) are required for a proliferative response than for effects on specific gene expression.
    Abdul-Wahab K; Corcoran D; Perachiotti A; Darbre PD
    Cell Prolif; 1999 Oct; 32(5):271-87. PubMed ID: 10619489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin-like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells.
    Tsonis AI; Afratis N; Gialeli C; Ellina MI; Piperigkou Z; Skandalis SS; Theocharis AD; Tzanakakis GN; Karamanos NK
    FEBS J; 2013 May; 280(10):2248-59. PubMed ID: 23374155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells.
    Stewart AJ; Johnson MD; May FE; Westley BR
    J Biol Chem; 1990 Dec; 265(34):21172-8. PubMed ID: 2174437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of receptors for epidermal growth factor and insulin-like growth factor I by ZR-75-1 human breast cancer cell variants is inversely related: the effect of steroid hormones on insulin-like growth factor I receptor expression.
    van den Berg HW; Claffie D; Boylan M; McKillen J; Lynch M; McKibben B
    Br J Cancer; 1996 Feb; 73(4):477-81. PubMed ID: 8595162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical effects of overexpression of the type I insulin-like growth factor (IGF) receptor on the responsiveness of human breast cancer cells to IGFs and estradiol.
    Daws MR; Westley BR; May FE
    Endocrinology; 1996 Apr; 137(4):1177-86. PubMed ID: 8625887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.
    Lee AV; Jackson JG; Gooch JL; Hilsenbeck SG; Coronado-Heinsohn E; Osborne CK; Yee D
    Mol Endocrinol; 1999 May; 13(5):787-96. PubMed ID: 10319328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation.
    Martin LA; Farmer I; Johnston SR; Ali S; Dowsett M
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S75-84. PubMed ID: 16113101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer.
    Iida M; Tsuboi K; Niwa T; Ishida T; Hayashi SI
    Breast Cancer; 2019 May; 26(3):272-281. PubMed ID: 30328006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status.
    Nesaretnam K; Stephen R; Dils R; Darbre P
    Lipids; 1998 May; 33(5):461-9. PubMed ID: 9625593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: interrelationships among insulin/insulin-like growth factor-I, serum, and estrogen.
    Katzenellenbogen BS; Norman MJ
    Endocrinology; 1990 Feb; 126(2):891-8. PubMed ID: 2404751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation.
    Chan CM; Martin LA; Johnston SR; Ali S; Dowsett M
    J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):333-41. PubMed ID: 12361723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between estradiol receptor and EGFR/IGF-IR signaling pathways in estrogen-responsive breast cancers: focus on the role and impact of proteoglycans.
    Skandalis SS; Afratis N; Smirlaki G; Nikitovic D; Theocharis AD; Tzanakakis GN; Karamanos NK
    Matrix Biol; 2014 Apr; 35():182-93. PubMed ID: 24063949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
    Boylan M; van den Berg HW; Lynch M
    Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
    Osborne CK; Coronado EB; Kitten LJ; Arteaga CI; Fuqua SA; Ramasharma K; Marshall M; Li CH
    Mol Endocrinol; 1989 Nov; 3(11):1701-9. PubMed ID: 2558302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine activation of the local insulin-like growth factor I system is up-regulated by estrogen receptor (ER)-independent estrogen actions and accounts for decreased ER expression in type 2 diabetic mesangial cells.
    Karl M; Potier M; Schulman IH; Rivera A; Werner H; Fornoni A; Elliot SJ
    Endocrinology; 2005 Feb; 146(2):889-900. PubMed ID: 15550505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol down-regulates the mannose-6-phosphate/insulin-like growth factor-II receptor gene and induces cathepsin-D in breast cancer cells: a receptor saturation mechanism to increase the secretion of lysosomal proenzymes.
    Mathieu M; Vignon F; Capony F; Rochefort H
    Mol Endocrinol; 1991 Jun; 5(6):815-22. PubMed ID: 1656243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen mitogenic action. ii. negative regulation of the steroid hormone-responsive growth of cell lines derived from human and rodent target tissue tumors and conceptual implications.
    Sirbasku DA; Moreno-Cuevas JE
    In Vitro Cell Dev Biol Anim; 2000; 36(7):428-46. PubMed ID: 11039494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
    Bradley LM; Gierthy JF; Pentecost BT
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line.
    Molloy CA; May FE; Westley BR
    J Biol Chem; 2000 Apr; 275(17):12565-71. PubMed ID: 10777546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.